340 related articles for article (PubMed ID: 29859654)
1. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
[TBL] [Abstract][Full Text] [Related]
2. Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis.
Giannelou M; Nezos A; Fragkioudaki S; Kasara D; Maselou K; Drakoulis N; Ioakeimidis D; Moutsopoulos HM; Mavragani CP
Clin Immunol; 2018 Aug; 193():110-117. PubMed ID: 29501539
[TBL] [Abstract][Full Text] [Related]
3. Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sjögren's syndrome: the impact of BAFF genetic variations.
Kintrilis N; Gravani F; Rapti A; Papaioannou M; Flessa CM; Nezos A; Antypa E; Papadaki I; Karageorgas Τ; Moutsopoulos HM; Mavragani CP
Rheumatology (Oxford); 2023 Feb; 62(2):958-968. PubMed ID: 35689637
[TBL] [Abstract][Full Text] [Related]
4. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
[TBL] [Abstract][Full Text] [Related]
5. High BAFF expression associated with active disease in systemic lupus erythematosus and relationship with rs9514828C>T polymorphism in TNFSF13B gene.
Marín-Rosales M; Cruz A; Salazar-Camarena DC; Santillán-López E; Espinoza-García N; Muñoz-Valle JF; Ramírez-Dueñas MG; Oregón-Romero E; Orozco-Barocio G; Palafox-Sánchez CA
Clin Exp Med; 2019 May; 19(2):183-190. PubMed ID: 30747361
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variants of the
Flessa CM; Zampeli E; Evangelopoulos ME; Natsis V; Bodewes ILA; Huijser E; Versnel MA; Moutsopoulos HM; Mavragani CP
Front Immunol; 2022; 13():836824. PubMed ID: 35371038
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K
Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
[TBL] [Abstract][Full Text] [Related]
8. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K
Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis.
Friebus-Kardash J; Trendelenburg M; Eisenberger U; Ribi C; Chizzolini C; Huynh-Do U; Lang KS; Wilde B; Kribben A; Witzke O; Dolff S; Hardt C
BMC Nephrol; 2019 Nov; 20(1):430. PubMed ID: 31752784
[TBL] [Abstract][Full Text] [Related]
10. B-cell activating factor and A proliferation-inducing ligand in relation to intima-media thickness as biomarkers of premature atherosclerosis in systemic lupus erythematosus patients.
Shater H; Fawzy M; Farid A; El-Amir A; Fouad S; Madbouly N
Am J Med Sci; 2022 Nov; 364(5):646-654. PubMed ID: 35580639
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic variation in B-cell activating factor with chronic hepatitis B virus infection.
Han Q; Yang C; Li N; Li F; Sang J; Lv Y; Zhao W; Li C; Liu Z
Immunol Lett; 2017 Aug; 188():53-58. PubMed ID: 28627389
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study.
Eilertsen GØ; Van Ghelue M; Strand H; Nossent JC
Rheumatology (Oxford); 2011 Dec; 50(12):2197-205. PubMed ID: 21984763
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.
Frerix M; Stegbauer J; Kreuter A; Weiner SM
Arthritis Res Ther; 2014 Feb; 16(1):R54. PubMed ID: 24548804
[TBL] [Abstract][Full Text] [Related]
14. B-cell activating factor promoter polymorphisms in egyptian patients with systemic lupus erythematosus.
Zayed RA; Sheba HF; Abo Elazaem MA; Elsaadany ZA; Elmessery LO; Mahmoud JA; Abdel Rahman DR; Abdou FR
Ann Clin Lab Sci; 2013; 43(3):289-94. PubMed ID: 23884224
[TBL] [Abstract][Full Text] [Related]
15. Human low-affinity IgG receptor FcγRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.
Clancy R; El Bannoudi H; Rasmussen SE; Bornkamp N; Allen N; Dann R; Reynolds H; Buyon JP; Berger JS
J Thromb Haemost; 2019 Mar; 17(3):532-537. PubMed ID: 30638300
[TBL] [Abstract][Full Text] [Related]
16. B-cell activating factor gene variants in multiple sclerosis: Possible associations with disease susceptibility among females.
Skarlis C; Papadopoulos V; Raftopoulou S; Mavragani CP; Evangelopoulos ME
Clin Immunol; 2023 Dec; 257():109847. PubMed ID: 37995946
[TBL] [Abstract][Full Text] [Related]
17. Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus.
González-Serna D; Ortiz-Fernández L; Vargas S; García A; Raya E; Fernández-Gutierrez B; López-Longo FJ; Balsa A; González-Álvaro I; Narvaez J; Gómez-Vaquero C; Sabio JM; García-Portales R; González-Escribano MF; Tolosa C; Carreira P; Kiemeney L; Coenen MJH; Witte T; Schneider M; González-Gay MÁ; Martín J
Sci Rep; 2018 May; 8(1):8195. PubMed ID: 29844438
[TBL] [Abstract][Full Text] [Related]
18. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
19. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
20. Mannose binding lectin gene polymorphism and preclinical carotid atherosclerosis in patients with systemic lupus erythematosus.
El-Sherif WT; Herdan OM; Osman MH; Alkady EA
Egypt J Immunol; 2010; 17(2):131-41. PubMed ID: 23082493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
